| Literature DB >> 35214638 |
Feifan Chen1, Yalin He1, Yuan Shi1.
Abstract
COVID-19 vaccination for children is crucial to achieve herd immunity. This is the first systematic review and meta-analysis to estimate parents' and guardians' willingness to vaccinate their children against COVID-19 and identify the determinants of vaccination intention. Systematic research was performed on the two databases (PubMed and EMBASE) from inception to 6 November 2021. Acceptance rates were pooled by use of a random-effects model and all predictors of vaccine acceptance were identified according to the health belief model (HBM) framework. This analysis was registered with PROSPERO (CRD42021292326) and reported in compliance with the PRISMA guidelines. Of 452 identified records, 29 eligible studies were included (N = 68,327 participants). The estimated worldwide vaccination acceptance rate was 61.40% (95% CI: 53.56-68.69%, I2 = 99.3%), ranging from 21.6% to 91.4% across countries and regions. In the determinant assessment, the age of parents and guardians, access to scientific information and recommendations, routine and influenza vaccination behavior, and the willingness of parents and guardians to vaccinate themselves were potentially significant predictors of the vaccination willingness. Given the limited quality and quantity of included articles, future studies with a rigorous design will be necessary for the confirmation of our findings.Entities:
Keywords: COVID-19; SARS-CoV-2; determinants; predictors; systematic review; vaccination hesitancy; vaccination willingness; vaccine
Year: 2022 PMID: 35214638 PMCID: PMC8880569 DOI: 10.3390/vaccines10020179
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Search terms used in PubMed.
| Mesh | Synonyms [Title/Abstract] |
|---|---|
| Infant OR Child OR Adolescent | Children OR adolescents OR adolescence OR teen OR teens OR teenager OR teenagers OR youth OR youths |
| SARS-CoV-2 OR COVID-19 | Coronavirus Disease 2019 Virus OR 2019 Novel Coronavirus OR 2019 Novel Coronaviruses OR SARS-CoV-2 Virus OR SARS-CoV-2 Virus OR SARS-CoV-2 Viruses OR 2019-nCoV OR COVID-19 Virus OR COVID 19 Virus OR COVID-19 Viruses OR SARS Coronavirus 2 OR Severe Acute Respiratory Syndrome Coronavirus 2 OR COVID 19 OR COVID-19 Virus Disease OR COVID 19 Virus Disease OR COVID-19 Virus Diseases OR COVID-19 Virus Infection OR COVID 19 Virus Infection OR COVID-19 Virus Infections OR 2019-nCoV Infection OR 2019 nCoV Infection OR 2019-nCoV Infections OR Coronavirus Disease-19 OR Coronavirus Disease 19 OR 2019 Novel Coronavirus Disease OR 2019 Novel Coronavirus Infection OR 2019-nCoV Disease OR 2019 nCoV Disease OR 2019-nCoV Diseases OR Coronavirus Disease 2019 OR SARS Coronavirus 2 Infection OR SARS-CoV-2 Infection OR SARS-CoV-2 Infection OR SARS-CoV-2 Infections |
| COVID-19 Vaccines OR | Vaccine OR vaccine OR vaccins OR vaccined OR vaccinal OR vaccinate OR vaccinated OR vaccinates OR vaccinator OR vaccinators OR vaccinating OR Vaccinations OR Active Immunization OR Active Immunizations |
| Surveys and Questionnaires OR Health Surveys | Survey OR surveys OR surveyed OR surveying OR questionnaire OR questionnaires OR questionnair |
Survey question responses categorized as vaccination-willingness.
| Attitude | Response |
|---|---|
| Vaccination willingness | Yes/Yes, definitely/Yes, as soon as it will be possible/Very likely |
| Vaccination refusal | No/No, never/No, definitely not/Not at all likely |
Figure 1PRISMA 2020 flow diagram for identification of studies via databases.
Characteristics of included studies.
| Author | Year | Continent | Country | Survey | Survey Method | Vaccination | Sample Size (n) | Quality of Study |
|---|---|---|---|---|---|---|---|---|
| Bagateli et al. [ | 2021 | South America | Brazil | hospital | offline | 458 | 501 | B |
| Marquez et al. [ | 2020 | North America | the United States | hospital | offline | 21 | 97 | C |
| Akarsu et al. [ | 2020 | Asia | Turkey | non-hospital | online | 97 | 232 | C |
| Aldakhil et al. [ | 2021 | Asia | Saudi Arabia | hospital | offline | 128 | 270 | B |
| Brandstetter et al. [ | 2020 | Europe | Germany | non-hospital | online | 312 | 612 | B |
| Hetherington et al. [ | 2020 | North America | Canada | hospital | online | 798 | 1321 | B |
| Montalti et al. [ | 2021 | Europe | Italy | non-hospital | online | 3017 | 4993 | A |
| Pierantoni et al. [ | 2020 | Europe | Italy | non-hospital | online | 1651 | 1812 | B |
| Scherer et al. [ | 2021 | North America | the United States | non-hospital | online | 567 | 1022 | B |
| Teasdale et al. [ | 2021 | North America | the United States | non-hospital | online | 1024 | 2074 | B |
| Temsah et al. [ | 2021 | Asia | Saudi Arabia | non-hospital | online | 1507 | 3167 | B |
| Wang et al. [ | 2020 | Asia | China | non-hospital | offline | 1784 | 3009 | A |
| Yang et al. [ | 2020 | Asia | China | non-hospital | online | 9122 | 12872 | A |
| Yigit et al. [ | 2020 | Asia | Turkey | hospital | offline | 243 | 428 | B |
| Yilmaz et al. [ | 2021 | Asia | Turkey | non-hospital | online | 376 | 1035 | B |
| Zhou et al. [ | 2020 | Asia | China | hospital | offline | 637 | 747 | A |
| Almusbah et al. [ | 2021 | Asia | Saudi Arabia | non-hospital | online | 256 | 1000 | B |
| Goldman et al. [ | 2020 | multi-continent | multi-country | hospital | online | 1006 | 1541 | A |
| Teasdale et al. [ | 2021 | North America | the United States | non-hospital | online | 693 | 1119 | B |
| Xu et al. [ | 2020 | Asia | China | non-hospital | online | 3451 | 4748 | A |
| Babicki et al. [ | 2021 | Europe | Poland | non-hospital | online | 2213 | 4432 | B |
| Wan et al. [ | 2021 | Asia | China | non-hospital | offline | 406 | 468 | A |
| Altulaihi et al. [ | 2021 | Asia | Saudi Arabia | hospital | offline | 179 | 333 | B |
| Goldman et al. [ | 2021 | multi-continent | multi-country | hospital | online | 1736 | 2769 | B |
| A et al. [ | 2020 | Asia | China | hospital | online | 6723 | 13451 | B |
| Bell et al. [ | 2020 | Europe | England | non-hospital | online | 1116 | 1252 | A |
| Humble et al. [ | 2020 | North America | Canada | non-hospital | online | 1074 | 1702 | A |
| Choi et al. [ | 2021 | Asia | Korea | hospital | offline | 145 | 226 | B |
| Evans et al. [ | 2021 | Oceania | Australian | non-hospital | online | 525 | 1094 | B |
Figure 2The forest plot of worldwide vaccination acceptance rate.
The results of subgroup analyses by characteristics of population.
| Subgroups | No. of Studies | Acceptance Rate (%) (95% CI) | I2 (%) | |
|---|---|---|---|---|
| Continent | <0.0001 | |||
| Asia | 14 | 58.33 [47.96, 68.01] | 99.5 | |
| Europe | 5 | 72.66 [51.99, 86.71] | 99.6 | |
| South America | 1 | 91.42 [88.63, 93.57] | - | |
| Oceania | 1 | 47.99 [45.04, 50.95] | - | |
| Multi-continents | 2 | 63.72 [61.90, 65.51] | 65.1 | |
| North America | 6 | 52.25 [40.77, 63.51] | 96.2 | |
| Country | <0.0001 | |||
| China | 6 | 72.57 [60.66, 81.95] | 99.7 | |
| Turkey | 3 | 44.78 [35.09, 54.89] | 96.1 | |
| Saudi Arabia | 4 | 42.95 [32.21, 54.40] | 98.1 | |
| Poland | 1 | 49.93 [48.46, 51.40] | - | |
| Brazil | 1 | 91.42 [88.63 93.57] | - | |
| England | 1 | 89.14 [87.29, 90.74] | - | |
| Germany | 1 | 50.98 [47.02, 54.93] | - | |
| Korea | 1 | 64.16 [57.70, 70.14] | - | |
| Australian | 1 | 47.99 [45.04, 50.95] | - | |
| Multi-country | 2 | 63.72 [61.90, 65.51] | 65.1 | |
| Canada | 2 | 61.91 [60.03, 63.75] | 56.3 | |
| the United States | 4 | 47.03 [32.02, 62.59] | 96.3 | |
| Italy | 2 | 79.80 [51.30, 93.68] | 99.8 | |
| Year | 0.3184 | |||
| 2020 | 14 | 65.26 [53.74, 75.24] | 99.5 | |
| 2021 | 15 | 57.63 [47.34, 67.30] | 98.7 | |
| Survey method | 0.4468 | |||
| online | 20 | 59.17 [50.80, 67.04] | 99.5 | |
| offline | 9 | 66.21 [49.33, 79.77] | 98.4 | |
| Survey sites | 0.9061 | |||
| hospital | 11 | 61.99 [49.04, 73.43] | 98.7 | |
| non-hospital | 18 | 61.04 [51.08, 70.16] | 99.5 | |
| Quality of study | < 0.0001 | |||
| A | 9 | 74.23 [65.61, 81.31] | 98.9 | |
| C | 2 | 31.60 [19.15, 47.40] | 91.4 |
The results of univariate and multivariate analyses on heterogeneity.
| Variables | Coefficient | 95% CI | Std. Err | ||
|---|---|---|---|---|---|
| Univariate Analysis | |||||
| Survey sites | Hospital | ref | ref | ref | ref |
| Non-hospital | −0.0401 | (−0.7038, 0.6236) | 0.3386 | 0.9057 | |
| Survey method | Offline | ref | ref | ref | ref |
| Online | −0.3043 | (−0.9927, 0.3841) | 0.3512 | 0.3863 | |
| Continent | America | ref | ref | ref | ref |
| Asia | −0.0607 | (−0.8293, 0.7079) | 0.3922 | 0.8770 | |
| Europe | 0.5792 | (−0.3907, 1.5492) | 0.4949 | 0.2418 | |
| Multi-continent | 0.1782 | (−1.1466, 1.5030) | 0.6759 | 0.7921 | |
| Oceania | −0.4779 | (−2.2446, 1.2887) | 0.9014 | 0.5960 | |
| Gender of | Male | ref | ref | ref | ref |
| Female | 0.7219 | (−1.5641, 3.0079) | 1.1664 | 0.5360 | |
| Education level | High school or lower | ref | ref | ref | ref |
| College or higher | −0.2851 | (−2.1543, 1.5841) | 0.9537 | 0.7650 | |
| Age of parents and guardians | ≥30 | ref | ref | ref | ref |
| <30 | 0.3633 | (−4.4087, 5.1354) | 2.4348 | 0.8814 | |
| Routine and influenza vaccination behavior | No | ref | ref | ref | ref |
| Yes | −0.4782 | (−2.5808, 1.6244) | 1.0728 | 0.6558 | |
| Vaccination willingness for self | No | ref | ref | ref | ref |
| Yes | 3.8195 | (2.4483, 5.1906) | 0.6996 | <0.001 | |
|
| |||||
| Gender of | Male | ref | ref | ref | ref |
| Female | 1.0154 | (−1.6611, 3.6919) | 1.3656 | 0.4571 | |
| Education level | High school or lower | ref | ref | ref | ref |
| College or higher | 1.3974 | (−0.7758, 3.5706) | 1.1088 | 0.2076 | |
| Vaccination willingness for self | No | ref | ref | ref | ref |
| Yes | 3.7930 | (2.0050, 5.5811) | 0.9123 | <0.001 | |
The results of pooled rates and pooled OR of studied determinants.
| Studied Items | No. of Studies | Pooled Rates (%) | Heterogeneity | Test of Heterogeneity | |
|---|---|---|---|---|---|
| Reasons for Unwillingness to Vaccinate the Children | |||||
| Safety, Side effect | 15 | 60.99 | 99.4 | <0.01 | |
| Novelty, | 11 | 54.40 | 99.6 | <0.01 | |
| Effectiveness | 12 | 24.20 | 98.8 | <0.01 | |
| Reasons for willingness to vaccinate the children | |||||
| Protection for children | 11 | 55.31 | 99.1 | <0.01 | |
|
|
|
|
|
| |
| Gender of parents and guardians | 11 | Female | ref | ref | ref |
| Male | 1.1130 | 98.8 | 0.7406 | ||
| Education level | 9 | College or higher | ref | ref | ref |
| High school or lower | 1.3795 | 93.6 | 0.2464 | ||
| Age of parents and guardians | 8 | ≥30 | ref | ref | ref |
| <30 | 0.6450 | 91.6 | <0.05 | ||
| Routine and influenza | 9 | No | ref | ref | ref |
| Yes | 2.1517 (1.2181,2.7696) | 92.4 | <0.01 | ||